A Switch in Therapy to a Reverse Transcriptase Inhibitor Sparing Combination of Lopinavir/Ritonavir and Raltegravir in Virologically Suppressed HIV-Infected Patients: A Pilot Randomized Trial to Assess Efficacy and Safety Profile: The KITE Study
-
- Ighovwerha Ofotokun
- Emory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia.
-
- Anandi N. Sheth
- Emory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia.
-
- Sara E. Sanford
- Emory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia.
-
- Kirk A. Easley
- Emory University Center for AIDS Research, Atlanta, Georgia.
-
- Neeta Shenvi
- Emory University School of Public Health, Biostatistics and Bioinformatics, Atlanta, Georgia.
-
- Kelly White
- Abbott Laboratories, Abbott Park, Illinois.
-
- Molly E. Eaton
- Emory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia.
-
- Carlos Del Rio
- Emory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia.
-
- Jeffrey L. Lennox
- Emory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, Georgia.
収録刊行物
-
- AIDS Research and Human Retroviruses
-
AIDS Research and Human Retroviruses 28 (10), 1196-1206, 2012-10
Mary Ann Liebert Inc